Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease

BACKGROUND: Apolipoprotein E (APOE) genotypes are associated with different plasma lipid levels. People with the APO epsilon 2 genotype can develop a disorder called dysbetalipoproteinemia (DBL). A possible predisposing factor for DBL is adiposity. We evaluated whether and to what extent the APOE genotype modifies the relation between adiposity and lipids in patients with manifest arterial disease and we looked at possible determinants of DBL in epsilon 2 homo-and heterozygote patients. METHODS: This prospective cohort study was performed in 5450 patients with manifest arterial disease from the Secondary Manifestations of ARTerial disease (SMART) study. The APOE genotype was measured in all patients and revealed 58 epsilon 2 homozygotes, 663 epsilon 2 heterozygotes, 3181 epsilon 3 homozygotes and 1548 epsilon 4 carriers. The main dependent variable was non-highdensity lipoprotein cholesterol (non-HDL-c). The relation between adiposity (including body mass index (BMI), waist circumference (waist), visceral adipose tissue (VAT) and metabolic syndrome (MetS)) and lipids was evaluated with linear regression analyses. Determinants of DBL were evaluated using logistic regression. RESULTS: There was significant effect modification by the APOE genotype on the relation between non-HDL-c and BMI, waist, VAT and MetS. There was an association between BMI and non-HDL-c in e2 homozygotes (beta 0.173, 95% confidence interval (CI) 0.031-0.314, P = 0.018) and e4 carriers (beta 0.033, 95% CI 0.020-0.046, P